9th Circ. Refuses To Revive Novartis Jaw Injury Suit
A Ninth Circuit panel on Thursday refused to revive a product liability lawsuit against Novartis Pharmaceuticals Corp. over jaw injuries allegedly related to bone drugs Aredia and Zometa, ruling that the...To view the full article, register now.
Already a subscriber? Click here to view full article